These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2004-004516-22 The impact of steroid hormones on symptom provocation in patients with premenstrual dysphoric disorder. not-yet-due
Completed, but no date 2004-004929-99 Cardiac effects of oxytocin administrated during cesarean section, signs of myocardial ischaemia. bad-data
Not reported 2004-005035-26 Methadone in chronic non-cancer pain: rotation from other opioids and choice of dose 2009-10-29 due-trials
Ongoing 2005-000654-67 Can patients with fibromyalgia be improved by subcutaneous injections of sterile water in tenderpoints? A randomised, controlled, tripple masked clinical trial not-yet-due
Listed as ongoing, but also has a completion date 2005-002003-17 High-dose therapy with autologous stem cell support in first line treatment of mantle cell lymphoma - Yttrium-90-ibritumomab tiuxetan in combination with BEAM or BEAC to improve outcome for patients n... 2015-04-13 bad-data
Ongoing 2005-003173-24 An open, randomized study treating refractory adult-onset Still´s disease (AOSD) with interleukin-1 receptor antagonist anakinra (KineretR), compared to an established, single anti-rheumatic drug trea... not-yet-due
Ongoing 2005-005565-10 Allopregnanolone effects on short term memory not-yet-due
Ongoing 2006-001128-38 DNA Vaccine Coding for the Rhesus Prostate Specific Antigen (rhPSA) and Electroporation in Patients with Relapsed Prostate Cancer. A Phase I/II Study not-yet-due
Completed, but no date 2006-002275-40 Prospective study of patients treated with pegylated interferon-alpha 2b (PegIntron) for metastasizing ileal/coecal carcinoids bad-data
Ongoing 2006-005239-32 Fosfodiesterashämmares akuta hemodynamiska effekter vid pulmonell hypertension och utvärdering av kväveoxid mätningar som icke-invasiv diagnostisk metod not-yet-due
Not reported 2006-005809-65 An open, fixed order, single center pharmacokinetic study of the influence of St John's wort on the pharmacokinetics and metabolism of fiansteride in healthy male subjects 2007-03-16 due-trials
Ongoing 2007-005109-23 Low-Dose Hormone Therapy Initiated early after Menopause and Changes in Artery Wall Composition (AWC), as Assesssed by High-Frequency Ultrasound. not-yet-due
Ongoing 2008-002636-15 Study on the treatment of therapy-resistant enuresis with desmopressin and reboxetine; a randomised, placebo-controlled, double-blinded, cross-over study not-yet-due
Ongoing 2008-003123-24 Neuroanatomical and functional abnormalities in patients with aversive effects from oral contraceptives. not-yet-due
Ongoing 2008-003581-26 Pharmacokinetics of levodopa using duodenal levodopa/carbidopa infusion with and without oral COMT inhibitors not-yet-due
Completed, but no date 2008-003594-41 An open label, multi-centre study of pasireotide LAR in addition to chemotherapy in patients with non-functioning, endocrine pancreatic tumors bad-data
Not reported 2008-005491-27 TAILORING OF PLATELET INHIBITION TO AVOID STENT THROMBOSIS 2010-02-28 due-trials
Ongoing 2008-005819-18 A comparison of Dysport (100 U/ml) and Botox (100 U/ml) using dose conversion factor 3:1 and 1.7:1 in the treatment of cervical dystonia. not-yet-due
Ongoing 2008-006410-20 Undersökning av en kväveoxidsyntashämmares effekt på smärta hos patienter med kronisk neuropatisk smärta. - Intravenös infusion med metylenblått not-yet-due
Ongoing 2008-006802-40 A PHASE II STUDY WITH OXALIPLATIN + 5FU + CETUXIMAB AND RADIOTHERAPY not-yet-due
Ongoing 2009-010609-35 Is treatment with emollients always beneficial? Comparative biophysical and molecularbiological studies of the skinbarrier function in patients with atopic dermatitis, ichtyosis vulgaris and x-linke... not-yet-due
Completed, but no date 2009-010783-41 Population pharmacokinetic and pharmacodynamic modeling of gabapentin in neuropathic pain - Effect of adjuvant pharmacotherapy bad-data
Ongoing 2009-011446-26 A randomized, placebo-controlled, double blind, parallel group phase II study of anti-ESBL IgY for the eradication of ESBL Klebsiella pneumoniae and Escherichia coli in faeces in carriers not-yet-due
Ongoing 2009-013684-19 Studie av botulinumtoxiners anhidrotiska (svettreducerande) effekt beroende på använd koncentration. not-yet-due
Ongoing 2009-016993-34 EUropean Pharmacogenetics of AntiCoagulation Therapy trial not-yet-due
Ongoing 2010-021061-72 To evaluate the safety and efficacy of a single subconjunctival injection of methylprednisolone versus standard postoperative steroid regiment in terms of intraocular inflammation and intraocular pres... not-yet-due
Ongoing 2010-023007-10 A neuroscience perspective on anxiety proneness - Sex differences, monoaminergic pathways and treatment response not-yet-due
Completed, reported early 2010-023103-94 PHASE I/IIa AdCD40L IMMUNOGENE THERAPY FOR MALIGNANT MELANOMA PATIENTS WITH DISSEMINATED DISEASE 2016-01-28 not-yet-due
Ongoing 2010-023560-40 Haematopoetic Stem Cell Therapy for Patients with Inflammatory Multiple Sclerosis Failing Alternate Approved Therapy: A Randomized Study not-yet-due
Not reported 2011-001481-18 Uncemented total hip implant and subcutaneous injection of Denosumab for patients with osteoarthritis of the hip. A randomised double blind placebo controlled study on the effects on bone evaluated wi... 2017-03-30 due-trials
Ongoing 2011-001998-10 An International Randomized Phase II Study Comparing Early Electrochemotherapy to Delayed or No Electrochemotherapy in Patients with Cutaneous Breast Cancer Metastases not-yet-due
Not reported 2011-004636-66 Single-blinded randomized trial of Botulinumtoxin A (Vistabel®) and its objective paralytic effect in the facial muscles of healthy women: development of new neurophysiological measurements. 2012-12-10 due-trials
Ongoing 2012-002217-19 Postoperative treatment with Vitamin D for patients with a history of Bariatric Surgery in C and U County. not-yet-due
Not reported 2012-005260-10 Bivalirudin versus Heparin in NST and ST-Evaluation myocardial infarction on modern antiplatelet therapy in SWEDEHEART (the VALIDATE - SWEDEHEART-trial) 2017-03-10 due-trials
Completed, but no date, and reported results 2012-005481-35 A controlled, randomized, assessor blinded, open-label study to investigate whether initiation of everolimus will reduce the incidence of developing a new Squamous Cell Carcinoma (SCC) and other malig... bad-data
Ongoing 2013-000925-30 How common are mood and sexual side-effects from combined oral contraceptives? not-yet-due
Ongoing 2013-001178-20 Cardiovascular (CV) risk prediction and CV biomarkers in renal transplant recipients treated with belatacept compared to calcineurin inhibitors (CNI). not-yet-due
Ongoing 2013-001244-56 An open, multicenter, single dose, parallel study, evaluating the pharmacokinetics of doxorubicin and its active metabolite (doxorubicinol) after a hepatic intra-arterial injection of either a lipiodo... not-yet-due
Completed, reported early 2013-001393-19 CD19-targeting 3rd generation CAR T cells for refractory B cell malignancy - a phase I/IIa trial. 2017-05-31 not-yet-due
Completed, report not yet due 2013-002736-24 Does Ticagrelor inhibit growth of small abdominal aortic aneurysms? A randomised controlled trial (TicAAA) 2017-08-18 not-yet-due
Completed, but no date 2013-004412-22 TRIAL OF CAFFEINE TO ALLEVIATE DYSPNEA RELATED TO TICAGRELOR bad-data
Ongoing 2014-000614-64 Study of recombinant adenovirus in patients with neuroendocrine tumors; safety and efficay not-yet-due
Completed, report not yet due 2014-000993-20 Dosing of intraarticular triamcinolone hexacetonid for knee synovitis in chronic polyarthritis 2017-11-13 not-yet-due
Not reported 2014-003432-39 A 24-week, single centre, randomized, parallel-group, double-blind, placebo controlled Phase II study to evaluate the efficacy on body weight of dapagliflozin 10 mg once daily in combination with exen... 2016-03-14 due-trials
Ongoing 2014-005174-11 A randomized, double-blinded placebo-controlled, paralleled designed, investigator sponsored study of the effect of the GLP-1 receptor agonist liraglutide on beta-cell function in C-peptide positive t... not-yet-due
Ongoing 2014-005416-42 Clondine in repeated doses for children in pain - a farmacokinetic study not-yet-due
Not reported 2015-001628-45 A parallel, double-blinded, randomized, 6 months, two arms study with lifestyle intervention and exenatide 2 mg once weekly or lifestyle intervention and placebo in adolescents with obesity to explore... 2016-09-13 due-trials
Ongoing 2015-003049-24 The Precision Hypertension Care study not-yet-due
Ongoing 2015-005549-30 A single-dose cross-over study to assess direct and indirect effects of dapagliflozin on pancreatic alpha and beta cells in patients with type 2 diabetes not-yet-due
Ongoing 2016-001719-19 Selecitve progesterone receptor modulators for treatment of premenstrual dysphoric disorder. A randomized, double-blind, placebo controlled study. not-yet-due
Ongoing 2016-002019-16 Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure with Preserved Ejection Fraction not-yet-due
Ongoing 2016-003275-22 Evaluation of the analgesic and sedative effects of dexmedetomidine for neonatal peripheral vein cannulation not-yet-due
Ongoing 2016-004106-34 PERSISTENCE OF MAJOR MOLECULAR REMISSION IN CHRONIC MYELOID LEUKEMIA AFTER a second stop of TKI TREATMENT in patients who failed an initial stop attempt: A prospective multicenter study . not-yet-due
Ongoing 2016-004264-19 Anesthesia with dexmedetomidine and fentanyl for neonatal surgery. A pilot study. not-yet-due
Ongoing 2017-002115-34 A multicenter phase II/III-study of 68Ga-ABY-025 PET for non-invasive quantification of HER2-expression in advanced breast cancer not-yet-due
Ongoing 2018-001115-73 A Phase I/II, 2-Arm, Open Label, Single Centre Study to Investigate the Safety and Effect of Oral GABA Therapy on β-cell Regeneration in Type 1-diabetes Patients not-yet-due